Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.

Abstract

The Stroke Prevention Trial in Sickle Cell Anemia (STOP) was a randomized trial to evaluate whether chronic transfusion could prevent initial stroke in children with sickle-cell anemia at high risk as determined by transcranial Doppler (TCD). The trial demonstrated a large benefit of transfusion and was halted early. After termination of the trial, patients… (More)

Topics

5 Figures and Tables

Cite this paper

@article{Lee2006StrokePT, title={Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results.}, author={Margaret T Y Lee and Sergio Piomelli and Suzanne Granger and Scott T. Miller and S. Suzan J. Harkness and D. Brambilla and Robert J. Adams}, journal={Blood}, year={2006}, volume={108 3}, pages={847-52} }